Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finke

Showing results (101-110 of 180) with videos related to

Pageof 18
Sort By:
Leukemia|October 8, 2013
U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotypeA Tefferi, C M Finke, T L Lasho, et al.
American Journal of Hematology|July 15, 2017
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevanceRangit Vallapureddy, Terra L Lasho, Katherine Hoversten, et al.
Leukemia|August 2, 2016
Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosisM M Patnaik, T L Lasho, C M Finke, et al.
American Journal of Hematology|February 15, 2016
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencingMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
Leukemia|November 26, 2011
Differential distribution of CCDC26 glioma-risk alleles in myeloid malignancies with mutant IDH1 compared with their IDH2R140-mutated or IDH-unmutated counterpartsT L Lasho, A Tefferi, A Pardanani, et al.
Blood Cancer Journal|January 24, 2015
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemiaT L Lasho, C M Finke, D Zblewski, et al.
Leukemia|January 30, 2010
MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasmsM M Patnaik, T L Lasho, C M Finke, et al.
American Journal of Hematology|March 9, 2018
U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlatesAyalew Tefferi, Mythri Mudireddy, Christy M Finke, et al.
American Journal of Hematology|August 15, 2018
Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patientsPrateek Pophali, Pedro Horna, Terra L Lasho, et al.
Blood Cancer Journal|January 24, 2018
EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimentalMrinal M Patnaik, Rangit Vallapureddy, Terra L Lasho, et al.
Pageof 18

Showing results (101-110 of 180) with videos related to

Sort By:
Pageof 18
Leukemia|October 8, 2013
U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotypeA Tefferi, C M Finke, T L Lasho, et al.
American Journal of Hematology|July 15, 2017
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevanceRangit Vallapureddy, Terra L Lasho, Katherine Hoversten, et al.
Leukemia|August 2, 2016
Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosisM M Patnaik, T L Lasho, C M Finke, et al.
American Journal of Hematology|February 15, 2016
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencingMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
Leukemia|November 26, 2011
Differential distribution of CCDC26 glioma-risk alleles in myeloid malignancies with mutant IDH1 compared with their IDH2R140-mutated or IDH-unmutated counterpartsT L Lasho, A Tefferi, A Pardanani, et al.
Blood Cancer Journal|January 24, 2015
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemiaT L Lasho, C M Finke, D Zblewski, et al.
Leukemia|January 30, 2010
MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasmsM M Patnaik, T L Lasho, C M Finke, et al.
American Journal of Hematology|March 9, 2018
U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlatesAyalew Tefferi, Mythri Mudireddy, Christy M Finke, et al.
American Journal of Hematology|August 15, 2018
Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patientsPrateek Pophali, Pedro Horna, Terra L Lasho, et al.
Blood Cancer Journal|January 24, 2018
EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimentalMrinal M Patnaik, Rangit Vallapureddy, Terra L Lasho, et al.
Pageof 18